Recombinant adeno-associated virus 8 vector in gene therapy: Opportunities and challenges

被引:20
作者
Zhao, Liyuan [1 ,2 ,4 ]
Yang, Zixuan [3 ]
Zheng, Minhui [3 ]
Shi, Lei [3 ]
Gu, Mengyun [3 ]
Liu, Gang [4 ]
Miao, Feng [4 ]
Chang, Yan [3 ]
Huang, Fanghua [5 ,7 ]
Tang, Naping [2 ,3 ,6 ]
机构
[1] Anhui Univ Tradit Chinese Med, Hefei 230000, Anhui, Peoples R China
[2] Yangtze Delta Pharmaceut Coll, Yangtze Delta Drug Adv Res Inst, Nantong 226133, Peoples R China
[3] Shanghai Duomirui Biotechnol Ltd, China State Inst Pharmaceut Ind, Shanghai 201203, Peoples R China
[4] InnoStar Biotech Nantong Co Ltd, Nantong 226133, Peoples R China
[5] Natl Med Prod Adm, Ctr Drug Evaluat, Beijing 100022, Peoples R China
[6] Shanghai Innostar Biotech Co Ltd, China State Inst Pharmaceut Ind, 199 Guoshoujing Rd, Shanghai 201203, Peoples R China
[7] Natl Med Prod Adm, Ctr Drug Evaluat, 128 Jianguo Rd, Beijing 100022, Peoples R China
关键词
AAV8; Adeno-associated virus; Gene therapy; Primates; Recombinant; Rodents; HEMOPHILIA-A MICE; NEUTRALIZING ANTIBODIES; EFFICIENT TRANSDUCTION; LIVER TRANSDUCTION; PERIPHERAL VEIN; RHESUS-MONKEYS; VIRAL VECTORS; MOUSE MODEL; AAV VECTOR; SEROTYPE-8;
D O I
10.1016/j.gendis.2023.02.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In recent years, significant breakthroughs have been made in the field of gene ther-apy. Adeno-associated virus (AAV) is one of the most promising gene therapy vectors and a powerful tool for delivering the gene of interest. Among the AAV vectors, AAV serotype 8 (AAV8) has attracted much attention for its efficient and stable gene transfection into specific tissues. Currently, recombinant AAV8 has been widely used in gene therapy research on a va-riety of diseases, including genetic diseases, cancers, autoimmune diseases, and viral diseases. This paper reviewed the applications and challenges of using AAV8 as a vector for gene ther-apy, with the aim of providing a valuable resource for those pursuing the application of viral vectors in gene therapy. 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:283 / 293
页数:11
相关论文
共 68 条
[1]   The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9 [J].
Akache, Bassel ;
Grimm, Dirk ;
Pandey, Kusum ;
Yant, Stephen R. ;
Xu, Hui ;
Kay, Mark A. .
JOURNAL OF VIROLOGY, 2006, 80 (19) :9831-9836
[2]  
[Anonymous], 2022, CELL GENE THERAPY
[3]   Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome [J].
Aronson, Sem J. ;
Veron, Philippe ;
Collaud, Fanny ;
Hubert, Aurelie ;
Delahais, Virginie ;
Honnet, Geraldine ;
de Knegt, Robert J. ;
Junge, Norman ;
Baumann, Ulrich ;
Di Giorgio, Angelo ;
D'Antiga, Lorenzo ;
Ginocchio, Virginia M. ;
Brunetti-Pierri, Nicola ;
Labrune, Philippe ;
Beuers, Ulrich ;
Bosma, Piter J. ;
Mingozzi, Federico .
HUMAN GENE THERAPY, 2019, 30 (10) :1297-1305
[4]   Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain [J].
Aschauer, Dominik F. ;
Kreuz, Sebastian ;
Rumpel, Simon .
PLOS ONE, 2013, 8 (09)
[5]   Widespread and Efficient Transduction of Spinal Cord and Brain Following Neonatal AAV Injection and Potential Disease Modifying Effect in ALS Mice [J].
Ayers, Jacob I. ;
Fromholt, Susan ;
Sinyavskaya, Olga ;
Siemienski, Zoe ;
Rosario, Awilda M. ;
Li, Andrew ;
Crosby, Keith W. ;
Cruz, Pedro E. ;
DiNunno, Nadia M. ;
Janus, Christopher ;
Ceballos-Diaz, Carolina ;
Borchelt, David R. ;
Golde, Todd E. ;
Chakrabarty, Paramita ;
Levites, Yona .
MOLECULAR THERAPY, 2015, 23 (01) :53-62
[6]   Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors [J].
Boutin, Sylvie ;
Monteilhet, Virginie ;
Veron, Philippe ;
Leborgne, Christian ;
Benveniste, Olivier ;
Montus, Marie Francoise ;
Masurier, Carole .
HUMAN GENE THERAPY, 2010, 21 (06) :704-712
[7]   Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or-2 serotypes for widespread gene delivery to the neonatal mouse brain [J].
Broekman, MLD ;
Comer, LA ;
Hyman, BT ;
Siena-Esteves, M .
NEUROSCIENCE, 2006, 138 (02) :501-510
[8]   Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial [J].
Casazza, Joseph P. ;
Cale, Evan M. ;
Narpala, Sandeep ;
Yamshchikov, Galina, V ;
Coates, Emily E. ;
Hendel, Cynthia S. ;
Novik, Laura ;
Holman, LaSonji A. ;
Widge, Alicia T. ;
Apte, Preeti ;
Gordon, Ingelise ;
Gaudinski, Martin R. ;
Conan-Cibotti, Michelle ;
Lin, Bob C. ;
Nason, Martha C. ;
Trofymenko, Olga ;
Telscher, Shinyi ;
Plummer, Sarah H. ;
Wycuff, Diane ;
Adams, William C. ;
Pandey, Janardan P. ;
McDermott, Adrian ;
Roederer, Mario ;
Sukienik, Avery N. ;
O'Dell, Sijy ;
Gall, Jason G. ;
Flach, Britta ;
Terry, Travis L. ;
Choe, Misook ;
Shi, Wei ;
Chen, Xuejun ;
Kaltovich, Florence ;
Saunders, Kevin O. ;
Stein, Judy A. ;
Doria-Rose, Nicole A. ;
Schwartz, Richard M. ;
Balazs, Alejandro B. ;
Baltimore, David ;
Nabel, Gary J. ;
Koup, Richard A. ;
Graham, Barney S. ;
Ledgerwood, Julie E. ;
Mascola, John R. .
NATURE MEDICINE, 2022, 28 (05) :1022-+
[9]   Treatment of Hepatocellular Carcinoma with Adeno-Associated Virus Encoding Interleukin-15 Superagonist [J].
Chang, Chia-Ming ;
Lo, Chia-Hui ;
Shih, Yao-Ming ;
Chen, Yin ;
Wu, Ping-Yi ;
Tsuneyama, Koichi ;
Roffler, Steve R. ;
Tao, Mi-Hua .
HUMAN GENE THERAPY, 2010, 21 (05) :611-621
[10]   Efficient Gene Delivery and Expression in Pancreas and Pancreatic Tumors by Capsid-Optimized AAV8 Vectors [J].
Chen, Min ;
Maeng, Kyungah ;
Nawab, Akbar ;
Francois, Rony A. ;
Bray, Julie K. ;
Reinhard, Mary K. ;
Boye, Sanford L. ;
Hauswirth, William W. ;
Kaye, Frederic J. ;
Aslanidi, Georgiy ;
Srivastava, Arun ;
Zajac-Kaye, Maria .
HUMAN GENE THERAPY METHODS, 2017, 28 (01) :49-59